Legal Representation
Attorney
Monica Riva Talley
USPTO Deadlines
Next Deadline
146 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
December 26, 2025
Extension Available
Until December 26, 2024
Application History
24 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 24, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 23, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| May 23, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 23, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Mar 3, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 13, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Dec 12, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Dec 12, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 3, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 2, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 2, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 2, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 5, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 26, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 29, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Nov 29, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Nov 29, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Oct 31, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 31, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 11, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 25, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 23, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 30, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 4, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products, namely, multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders
Class 042
Discovery in the nature of pharmaceutical research, development, engineering and testing, namely, for multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders
Classification
International Classes
005
042